Recommendations for defining and treating high risk localized prostate cancer.

作者信息

Thompson Ian M, Carroll Peter R, Carducci Michael A

机构信息

Department of Urology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA.

出版信息

J Urol. 2006 Dec;176(6 Pt 2):S6-S10; quiz S3-5. doi: 10.1016/j.juro.2006.09.016.

DOI:10.1016/j.juro.2006.09.016

PMID:17084170

Abstract

摘要

相似文献

Recommendations for defining and treating high risk localized prostate cancer.

J Urol. 2006 Dec;176(6 Pt 2):S6-S10; quiz S3-5. doi: 10.1016/j.juro.2006.09.016.

A critical review of clinical practice guidelines for the management of clinically localized prostate cancer.

J Urol. 2008 Aug;180(2):451-9; discussion 460. doi: 10.1016/j.juro.2008.04.004. Epub 2008 Jun 11.

Advanced prostate cancer treatment guidelines: European perspective.

BJU Int. 2004 Dec;94 Suppl 3:6. doi: 10.1111/j.1464-410X.2004.05136.x.

Global update on defining and treating high-risk localized prostate cancer with leuprorelin: a USA perspective--identifying men at diagnosis who are at high risk of prostate cancer death after surgery or radiation therapy.

BJU Int. 2007 Jan;99 Suppl 1:13-6; discussion 17-8. doi: 10.1111/j.1464-410X.2007.06594.x.

Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes.

J Urol. 2007 Feb;177(2):540-5. doi: 10.1016/j.juro.2006.10.097.

Long-term survival in men with high grade prostate cancer: a comparison between conservative treatment, radiation therapy and radical prostatectomy--a propensity scoring approach.

J Urol. 2007 Mar;177(3):911-5. doi: 10.1016/j.juro.2006.10.040.

Prostate cancer in the elderly.

Urol Oncol. 2009 Nov-Dec;27(6):668-72. doi: 10.1016/j.urolonc.2009.07.015.

Caring for a patient with metastatic prostate cancer.

Nursing. 2008 Jun;38(6):52-6. doi: 10.1097/01.NURSE.0000320359.09574.5c.

Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality.

J Natl Cancer Inst. 2007 Oct 17;99(20):1516-24. doi: 10.1093/jnci/djm168. Epub 2007 Oct 9.

Adjuvant therapy after radical prostatectomy: clinical considerations.

Surg Oncol. 2009 Sep;18(3):247-54. doi: 10.1016/j.suronc.2009.02.005. Epub 2009 Mar 12.

引用本文的文献

Efficacy and Safety of Neoadjuvant Luteinizing Hormone-Releasing Hormone Antagonist and Tegafur-Uracil Chemohormonal Therapy for High-Risk Prostate Cancer.

Life (Basel). 2023 Apr 23;13(5):1072. doi: 10.3390/life13051072.

Building Data-Driven Pathways From Routinely Collected Hospital Data: A Case Study on Prostate Cancer.

JMIR Med Inform. 2015 Jul 10;3(3):e26. doi: 10.2196/medinform.4221.

Robotic radical prostatectomy in high-risk prostate cancer: current perspectives.

Asian J Androl. 2015 Nov-Dec;17(6):908-15; discussion 913. doi: 10.4103/1008-682X.153541.

The role of radical prostatectomy in high-risk prostate cancer.

Prostate Int. 2013;1(3):95-101. doi: 10.12954/PI.13018. Epub 2013 Sep 27.

Radical prostatectomy as primary treatment of high-risk prostate cancer.

Curr Urol Rep. 2012 Apr;13(2):179-86. doi: 10.1007/s11934-012-0240-6.

The benefits and risks of testosterone replacement therapy: a review.

Ther Clin Risk Manag. 2009 Jun;5(3):427-48. doi: 10.2147/tcrm.s3025. Epub 2009 Jun 22.

Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations.

Eur J Endocrinol. 2008 Nov;159(5):507-14. doi: 10.1530/EJE-08-0601.

High-risk, clinically localized prostate cancer: is monotherapy adequate?

Rev Urol. 2007;9 Suppl 2(Suppl 2):S19-27.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验